Title:
肺癌マーカー補体Ｃ３ｄｇ分子及び肺癌マーカーの分析方法
Document Type and Number:
Japanese Patent JP5867834
Kind Code:
B2
Abstract:
[Problem] To provide a method for detecting early-stage lung cancer, which reduce a burden on a subject and are excellent in specificity and sensitivity. [Solution] A lung cancer marker comprising a complement C3dg molecule. A method for analyzing a lung cancer marker comprising the steps of: measuring a level of a complement C3dg molecule as a lung cancer marker in a biological sample to acquire a measured level of the complement C3dg molecule; and making an evaluation as to whether the measured level is high or low based on a reference level of the complement C3dg molecule. Preferably, the measured level of the complement C3dg molecule is a value relative to a measured level of a complement C3 full-length molecule in the biological sample, and herein the reference level of the complement C3dg molecule is a value relative to a reference level of the complement C3 full-length molecule.
More Like This:
Inventors:
Toyama Atsuhiko
Takaaki Sato
Ueda Koji
Takaaki Sato
Ueda Koji
Application Number:
JP2013533539A
Publication Date:
February 24, 2016
Filing Date:
March 19, 2012
Export Citation:
Assignee:
SHIMADZU CORPORATION
RIKEN
RIKEN
International Classes:
G01N33/53; G01N27/62; G01N33/574
Domestic Patent References:
| JP2007051880A | ||||
| JP6065293A | ||||
| JP2011006478A | ||||
| JP2007501948A |
Other References:
吉田 浩 ,免疫学的検査 D.免疫複合体 免疫複合体検出方法 抗C3d-IgG抗体法 ,日本臨床,日本,2010年 6月20日,Vol.68,増刊号6,Page.116-118
Attorney, Agent or Firm:
Masahiro Okada